Bicara Therapeutics Inc. (BCAX)

CIK 2023658 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bicara Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 202640001470831-26-000883
Sep 8, 20261440001969223-26-001009
Sep 8, 20261440001969223-26-001008
Aug 25, 20268-K0001628280-26-058937
Aug 14, 202630001470831-26-000818
Aug 14, 202640001470831-26-000819
Aug 13, 2026SCHEDULE 13G/A0001274173-26-000198
Aug 12, 202640001470831-26-000813
Aug 12, 202640001470831-26-000812
Aug 12, 202640001470831-26-000814
Aug 11, 2026S-80001628280-26-055779
Aug 11, 202610-Q0001628280-26-055765
Aug 11, 20268-K0001628280-26-055500
Aug 10, 20261440001969223-26-000872
Aug 10, 20261440001969223-26-000869
Aug 10, 20261440001969223-26-000873
Jul 29, 202640001470831-26-000737
Jul 29, 202630001470831-26-000735
Jul 29, 202640001470831-26-000738
Jul 29, 202630001470831-26-000736
Jul 28, 20268-K0001628280-26-049937
Jul 27, 2026SCHEDULE 13G0002012383-26-002268
Jul 14, 202640001470831-26-000714
Jul 10, 202640001470831-26-000700
Jul 10, 20261440001969223-26-000775